case_images: PMC6011174_01
case_images: Chest radiograph upon the start of high-dose corticosteroid therapy. Infiltrative shadows are clearly observed in both lung fields.
case_images: CRICC2018-9790459.001.jpg
case_images: PMC6011174_01_CRICC2018-9790459.001.jpg
case_images: fig1
case_images: A chest X-ray (Figure 1) revealed infiltrative shadows in both lung fields, with greater density in the right lung.
case_images: CT scan upon the start of high-dose corticosteroid therapy. The scan shows bilateral pulmonary infiltrates along the peripheral bronchovascular bundles and ground-glass opacities with a panlobular distribution.
case_images: CRICC2018-9790459.002.jpg
case_images: PMC6011174_01_CRICC2018-9790459.002.jpg
case_images: fig2
case_images: A computed tomography (CT) scan showed pulmonary infiltrates along the peripheral bronchovascular bundles and ground-glass opacities (Figure 2).
case_images: CT scan after extubation. The pulmonary infiltrates and ground-glass opacities had disappeared.
case_images: CRICC2018-9790459.003.jpg
case_images: PMC6011174_01_CRICC2018-9790459.003.jpg
case_images: fig3
case_images: During approximately 3 consecutive weeks of APRV and steroid therapy, the patient demonstrated gradual improvements in respiratory function, and a CT scan after extubation showed that the pulmonary infiltrates and ground-glass opacities had disappeared (Figure 3).